Please assess the completion status of the following clinical trial:

Trial Title: Beta Blockers Versus Variceal Band Ligation and Beta Blockers for Primary Prophylaxis of Variceal Bleeding

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* cirrhosis~* medium to large varices~Exclusion Criteria:~* contraindications to beta blockers~* refusal to give consent~* prior history of variceal hemorrhage~* creatinine \> 1.5 mg/dl

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): endoscopic variceal band ligation
- 2 (Type: ACTIVE_COMPARATOR): subjects will receive nadolol (beta blocker) at 20mg/day with dose titration

Based on this trial design, predict the completion outcome and termination type (if applicable).